Skip to content
PICO Portalanswers from OpenAlex

Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression

PaperCitations, authors & open-access status

Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression is a paper indexed in PICO Portal from OpenAlex.

How many citations does Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression have?

PICO Portalcitation count

Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression has 127 citations in the OpenAlex counts PICO Portal stores.

When was Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression published?

PICO Portalyear

Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression has 2018 year in the PICO Portal index.

What is the open-access status of Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression?

PICO Portaloa status

Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression has gold oa status in the PICO Portal index.

What is the DOI of Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression?

PICO Portaldoi

The DOI for Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression is on the source record.

What is the PMID of Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression?

PICO Portalpmid

The PMID for Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression is on the source record.

What is the OpenAlex record for Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression?

PICO Portalopenalex

The OpenAlex for Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial